May 25, 2020 8:00am EDT Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19
May 15, 2020 8:30am EDT Algernon Submits for Ethics Approval in Australia for Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
May 06, 2020 8:30am EDT Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia
Apr 30, 2020 9:15am EDT Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
Apr 29, 2020 3:09pm EDT Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
Apr 29, 2020 8:30am EDT Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD
Apr 23, 2020 7:30am EDT Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
Apr 22, 2020 7:30am EDT Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
Apr 15, 2020 8:30am EDT Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation
Apr 13, 2020 11:34am EDT Algernon CEO and CSO to be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
